Hayat Hospital (Dibrugarh) Profile
Key Indicators
- Authorised Capital ₹ 4.10 Cr
- Paid Up Capital ₹ 4.01 Cr
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -425.59%
- Ebitda -382.73%
- Net Worth -0.04%
- Total Assets 19.33%
About Hayat Hospital (Dibrugarh)
Hayat Hospital (Dibrugarh) Private Limited (HHDPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2017 (Seven years and three months 0 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.10 Cr and a paid-up capital of Rs 4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajib Saikia and Shareen Rahman serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85310AS2017PTC018217
-
Company No.
018217
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Hayat Hospital (Dibrugarh)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Saikia
|
Director | 09-Nov-2017 | Current |
|
Shareen Rahman
|
Director | 09-Nov-2017 | Current |
Financial Performance of Hayat Hospital (Dibrugarh).
Hayat Hospital (Dibrugarh) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 425.59% decrease in profit. The company's net worth dipped by a decrease of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hayat Hospital (Dibrugarh)?
In 2021, Hayat Hospital (Dibrugarh) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hayat Hospital Private LimitedRajib Saikia and Shareen Rahman are mutual person
-
Shyamashree Finvest Pvt LtdRajib Saikia and Shareen Rahman are mutual person
-
Neza Sales Private Limited
Rajib Saikia is a mutual person
-
Hayat Clinic And Diagnostics Private Limited
Rajib Saikia and Shareen Rahman are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hayat Hospital (Dibrugarh)?
Unlock and access historical data on people associated with Hayat Hospital (Dibrugarh), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hayat Hospital (Dibrugarh), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hayat Hospital (Dibrugarh)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
